These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7687742)

  • 1. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
    Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
    Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible v-Crk-induced transformation through activation of Src kinases.
    Sabe H; Shoelson SE; Hanafusa H
    J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
    Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
    J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
    Hempstead BL; Birge RB; Fajardo JE; Glassman R; Mahadeo D; Kraemer R; Hanafusa H
    Mol Cell Biol; 1994 Mar; 14(3):1964-71. PubMed ID: 7509449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
    Akagi T; Murata K; Shishido T; Hanafusa H
    Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.
    Mayer BJ; Hanafusa H
    J Virol; 1990 Aug; 64(8):3581-9. PubMed ID: 1695251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
    Fajardo JE; Birge RB; Hanafusa H
    Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region.
    Turner CE; Miller JT
    J Cell Sci; 1994 Jun; 107 ( Pt 6)():1583-91. PubMed ID: 7525621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells.
    Ribon V; Saltiel AR
    J Biol Chem; 1996 Mar; 271(13):7375-80. PubMed ID: 8631760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk.
    Schaller MD; Parsons JT
    Mol Cell Biol; 1995 May; 15(5):2635-45. PubMed ID: 7537852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
    Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
    Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.
    Mayer BJ; Hanafusa H
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2638-42. PubMed ID: 1690891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
    Grgurevich S; Mikhael A; McVicar DW
    Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
    Matsuda M; Mayer BJ; Hanafusa H
    Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells.
    Weng Z; Taylor JA; Turner CE; Brugge JS; Seidel-Dugan C
    J Biol Chem; 1993 Jul; 268(20):14956-63. PubMed ID: 8325872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
    Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
    J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-Crk-induced cell transformation: changes in focal adhesion composition and signaling.
    Nievers MG; Birge RB; Greulich H; Verkleij AJ; Hanafusa H; van Bergen en Henegouwen PM
    J Cell Sci; 1997 Feb; 110 ( Pt 3)():389-99. PubMed ID: 9057091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
    Reichman CT; Mayer BJ; Keshav S; Hanafusa H
    Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.